Publicaciones en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (7)

2024

  1. The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

    Matrix Biology, Vol. 132, pp. 1-9

2021

  1. Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus

    Nature Genetics, Vol. 53, Núm. 11, pp. 1606-1615

  2. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

2010

  1. Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009

    Cancer Immunology, Immunotherapy

2005

  1. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms

    Oncogene, Vol. 24, Núm. 5, pp. 790-800

1997

  1. Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

    Hepatology, Vol. 25, Núm. 2, pp. 470-477

1995

  1. Neuronal nitric oxide synthase immunoreactivity in the respiratory tract of the frog, Rana temporaria

    The Histochemical Journal, Vol. 27, Núm. 10, pp. 812-818